EyePoint Pharmaceuticals Files 8-K
Ticker: EYPT · Form: 8-K · Filed: Nov 19, 2025 · CIK: 1314102
| Field | Detail |
|---|---|
| Company | Eyepoint Pharmaceuticals, Inc. (EYPT) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-actions
Related Tickers: EYPT
TL;DR
EYPT filed an 8-K on 11/19/25, standard disclosure.
AI Summary
EyePoint Pharmaceuticals, Inc. filed an 8-K on November 19, 2025, reporting other events and financial statements. The company, formerly known as pSivida Corp. and pSivida LTD, is incorporated in Delaware and headquartered in Watertown, Massachusetts.
Why It Matters
This filing indicates a routine update or event for EyePoint Pharmaceuticals, Inc., requiring disclosure to the SEC.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for reporting events and financial statements, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 000-51122 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-2774444 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- EyePoint Pharmaceuticals, Inc. (company) — Registrant
- pSivida Corp. (company) — Former company name
- pSivida LTD (company) — Former company name
- November 19, 2025 (date) — Date of earliest event reported
- Watertown, Massachusetts (location) — Principal Executive Offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as the items being reported, but the specific event is not detailed in the provided text.
When was EyePoint Pharmaceuticals, Inc. previously known by other names?
The company was formerly known as pSivida Corp. after changing its name from pSivida LTD on June 19, 2008, and January 11, 2005, respectively.
Where are EyePoint Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 480 Pleasant Street, Suite C400, Watertown, Massachusetts, 02472.
What is the SIC code for EyePoint Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 3826, which corresponds to Laboratory Analytical Instruments.
What is the fiscal year end for EyePoint Pharmaceuticals, Inc.?
The company's fiscal year ends on December 31.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-11-19 07:05:14
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 EYPT The Nasdaq Global Market Indi
Filing Documents
- d65451d8k.htm (8-K) — 25KB
- d65451dex991.htm (EX-99.1) — 22KB
- g65451dsp05.jpg (GRAPHIC) — 6KB
- 0001193125-25-286961.txt ( ) — 171KB
- eypt-20251119.xsd (EX-101.SCH) — 3KB
- eypt-20251119_lab.xml (EX-101.LAB) — 17KB
- eypt-20251119_pre.xml (EX-101.PRE) — 11KB
- d65451d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of EyePoint Pharmaceuticals, Inc. dated November 19, 2025 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYEPOINT PHARMACEUTICALS, INC. Date: November 19, 2025 By: /s/ George O. Elston George O. Elston Executive Vice President and Chief Financial Officer